Effect of Hemodialysis on Total and Free Lenvatinib Concentrations in a Patient With Metastatic Renal Cell Carcinoma
Although the free LEN concentration is reduced just after HD, LEN will have sufficient pharmacological activity on HD days for patients undergoing HD.
Authors
- Kazuo Matsubara
- Manabu Suno (ORCID: https://orcid.org/0000-0002-1511-7725)
- Yasuo Kohjimoto (ORCID: https://orcid.org/0000-0001-6103-6320)
- Shimpei Yamashita (ORCID: https://orcid.org/0000-0001-7402-6164)
- Takahiro Ito (ORCID: https://orcid.org/0000-0002-1876-3052)
- Atsushi Iwata (ORCID: https://orcid.org/0000-0001-7308-5314)
Institutions
- Wakayama Medical University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1002/iju5.70099
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00